Proteinase K Global Market Report 2026

Proteinase K, a serine protease derived from the mold Tritirachium album, serves as a valuable enzyme for the deactivation of protein contaminants in sample preparations. Widely utilized in DNA extraction processes, this enzyme comes in two primary forms lyophilized powder and liquid.

The lyophilized powder form is obtained through a dehydration process involving freezing and vacuum removal of water. Proteinase K finds applications across various therapeutic areas such as infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, and neurology. Its uses extend to isolation and purification of genomic DNA and RNA, in situ hybridization, mitochondria isolation, and enzyme removal.Target customers for Proteinase K include contract research organizations, academic institutes, biotechnology companies, and diagnostics laboratories. Its role in facilitating the efficient processing of samples makes it a key component in research and diagnostic workflows within the specified industries and applications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the proteinase k market by increasing costs of imported fermentation inputs, purification reagents, laboratory-grade packaging, and cold-chain logistics materials. Biotechnology companies and research institutions in North America and Europe are most affected due to reliance on imported enzyme raw materials, while Asia-Pacific faces cost pressure on export-oriented reagent manufacturing. These tariffs are raising reagent prices and procurement costs. However, they are also supporting local enzyme production, regional bioprocessing facilities, and innovation in cost-efficient enzyme manufacturing.

The proteinase k market research report is one of a series of new reports from The Business Research Company that provides proteinase k market statistics, including proteinase k industry global market size, regional shares, competitors with a proteinase k market share, detailed proteinase k market segments, market trends and opportunities, and any further data you may need to thrive in the proteinase k industry. This proteinase k market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The proteinase k market size has grown rapidly in recent years. It will grow from $5.29 billion in 2025 to $5.86 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to expansion of molecular biology research, growth of academic and clinical laboratories, increasing use of genomic sequencing techniques, rising demand for reliable sample preparation enzymes, availability of standardized enzyme formulations.

The proteinase k market size is expected to see rapid growth in the next few years. It will grow to $8.91 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to increasing investments in precision medicine, rising adoption of advanced diagnostic testing, expansion of biotechnology research pipelines, growing demand for automation-compatible reagents, increasing focus on reproducible research outcomes. Major trends in the forecast period include increasing demand for high-purity enzymes, rising use in dna and rna extraction protocols, growing adoption in molecular diagnostics, expansion of genomics research activities, enhanced focus on sample preparation accuracy.

An increasing prevalence of chronic diseases is expected to drive the growth of the proteinase K market going forward. Chronic diseases are conditions or illnesses that last more than a year and require ongoing medical care. Proteinase K is used in these conditions in preventative or therapeutic applications to extract and isolate DNA (Deoxyribonucleic Acid) and RNA (Ribonucleic Acid) from viruses responsible for various chronic diseases. For example, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older with at least one chronic condition is projected to reach 142.66 million by 2050. Thus, the rising prevalence of chronic diseases is propelling the proteinase K market.

The increasing incidence of infectious diseases, such as tuberculosis, is also expected to boost the growth of the proteinase K market. Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis, which primarily affects the lungs but can impact other parts of the body. Proteinase K is used in TB research to extract and isolate DNA and RNA from the Mycobacterium tuberculosis bacterium. For instance, in February 2024, according to GOV.UK, a UK-based government department, tuberculosis cases in England increased by 10.7% in 2023, rising from 4,380 in 2022 to 4,850. Therefore, the growing incidence of infectious diseases such as tuberculosis is driving the proteinase K market.

In January 2023, Lighthouse Pharma, a US-based biopharmaceutical company, acquired the small molecule proteinase inhibitor portfolio from Quince Therapeutics Inc. This acquisition positions Lighthouse Pharma to advance the development of gingipain inhibitors for dementia and other disorders, offering innovative treatment options. Quince Therapeutics Inc., a US-based biotechnology company specializing in proteinase inhibitors, contributes valuable assets to Lighthouse Pharma's research and development efforts.

Major companies operating in the proteinase k market are Merck KGaA, Thermo Fisher Scientific, Qiagen, Roche Holding, Takara Bio, New England Biolabs, Promega Corporation, Bio-Rad Laboratories, Agilent Technologies, Abcam plc, GenScript Biotech, Enzo Life Sciences, PerkinElmer, Bio-Techne, Miltenyi Biotec, Sartorius AG, Lonza Group, FUJIFILM Irvine Scientific, MP Biomedicals, Nacalai Tesque, PanReac AppliChem

North America was the largest region in the global proteinase K market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global proteinase k market during the forecast period. The regions covered in the proteinase k market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the proteinase k market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The proteinase K market consists of sales of acid proteinase, neutral proteinase, and alkaline proteinase. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Proteinase K Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses proteinase k market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for proteinase k ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The proteinase k market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Lyophilized Powder Form; Liquid Form
• 2) By Application: Isolation And Purification Of Genomic DNA And RNA; In Situ Hybridization; Mitochondria Isolation; Enzyme Removal
• 3) By End-Use: Contract Research Organization; Academic Institutes; Biotechnology Companies; Diagnostic Laboratories
• Subsegments:
• 1) By Lyophilized Powder Form: High Purity Lyophilized Powder; Standard Grade Lyophilized Powder
• 2) By Liquid Form: Ready-To-Use Liquid; Concentrated Liquid Solutions
• Companies Mentioned: Merck KGaA; Thermo Fisher Scientific; Qiagen; Roche Holding; Takara Bio; New England Biolabs; Promega Corporation; Bio-Rad Laboratories; Agilent Technologies; Abcam plc; GenScript Biotech; Enzo Life Sciences; PerkinElmer; Bio-Techne; Miltenyi Biotec; Sartorius AG; Lonza Group; FUJIFILM Irvine Scientific; MP Biomedicals; Nacalai Tesque; PanReac AppliChem
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.